⚡ Flash Summary

Wah Nobel Chemicals Limited’s first quarter ended September 30, 2025, shows positive financial performance. Net sales revenue increased by 17% year-over-year, reaching Rs 1.413 billion compared to Rs 1.203 billion in the previous year. After-tax profit also rose to Rs 122 million from Rs 111 million in the corresponding period last year. The company’s management expresses a positive outlook, aiming for continued growth and operational efficiency amid challenging economic conditions.

📌 Key Takeaways

• 🎉 Net Sales Revenue increased by 17% reaching Rs 1.413 billion compared to Rs 1.203 billion last year.
• 📈 After Tax Profit improved to Rs 122 million from Rs 111 million YoY.
• 💪 Company holds ISO 9001:2008, 14001:2004 & OHSAS 18001:2007 certifications.
• 🏢 Registered office is located in G.T. Road, Wah Cantt.
• 🌐 Company website: www.wahnobel.com.
• 🌱 Company manufactures Urea Formaldehyde Moulding Compound, Formaldehyde and Formaldehyde based liquid resins.
• 🏦 Bankers include MCB Bank Limited, Allied Bank, Bank Al-Habib, Askari Bank, Meezan Bank, and Faysal Bank.
• ✅ Basic and diluted earnings per share increased to Rs 13.58 compared to Rs 12.31 YoY.
• 💰 Cash and cash equivalents decreased to Rs (63.161) million from Rs 484.280 million.
• 📊 Total Equity increased from Rs 2,654.312 million to Rs 2,776.507 million.
• liabilities increased from Rs 1,186.376 million to Rs 1,083.138 million.
• 🏭 Company’s factory is located in Wah Cantt.
• 📜 Board proposed a cash dividend of Rs 10 per share for the year ended June 30, 2025.
• 🤝 Wah Nobel (Private) Ltd (WNPL) holds 55.23% shares of the company.

🎯 Investment Thesis

Based on the positive Q1 results, a BUY recommendation is warranted. The company’s revenue and profit growth, coupled with a positive management outlook, present an attractive investment opportunity. I set a price target of PKR 175, with a time horizon of 12 months, assuming the company continues its growth trajectory and effectively manages its cash flow and operational efficiencies. This price target is based on an expected earnings multiple expansion, driven by improved investor confidence and market conditions.